Skip to main content

Table 2 Minimal biofilm inhibitory and eradication concentrations (MBIC and MBEC) determined by resazurin and cell counting methods

From: Defining conditions for biofilm inhibition and eradication assays for Gram-positive clinical reference strains

Bacterial strain

Antibiotic

MICa (μg/mL)

MBIC (μg/mL)

MBEC (μg/mL)

Resazurin

CFU/mLb

Resazurin

CFU/mLb

(decrease in RFU)

(growth inhibition)

(decrease in RFU)

(log10 reduction)

Staphylococcus aureus ATCC 29213

Ciprofloxacin

0.5

1 (99%)

1 (100%)

>  160 (18%)

>  160 (1.2)

Staphylococcus aureus MRSA ATCC 43300

Ciprofloxacin

0.5

1 (99%)

1 (100%)

>  160 (30%)

>  160 (1.7)

Enterococcus faecalis ATCC 29212

Ciprofloxacin

1

1 (90%)

1 (100%)

>  160 (35%)

>  160 (4.0)

Enterococcus faecalis VRE ATCC 51575

Ciprofloxacin

0.5

1 (99%)

1 (100%)

>  160 (0%)

>  160 (3.3)

Enterococcus faecium ATCC 35667

Linezolid

4

2 (96%)

2 (100%)

>  80 (26%)

>  80 (1.5)

Enterococcus faecium VRE ATCC 70021

Linezolid

2

2 (99%)

2 (97%)

>  80 (26%)

>  80 (1.8)

  1. Mean of quality parameters of MBIC and MBEC assays were: Z’ = 0.83; S/B = 14.83, SW = 36.40 and Z’ = 0.77; S/B = 21.19 and SW = 17.19, respectively
  2. a:Minimal inhibitory concentration previously determined by our group
  3. b:For each experiment, initial biofilm cell populations were determined and used for the calculations of growth inhibition and log10 reduction